Skip to main content
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.330
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.300
-0.030 (-2.26%)
After-hours: Mar 9, 2026, 5:42 PM EDT

Vivos Therapeutics Revenue

Vivos Therapeutics had revenue of $6.78M in the quarter ending September 30, 2025, with 75.73% growth. This brings the company's revenue in the last twelve months to $17.32M, up 18.76% year-over-year. In the year 2024, Vivos Therapeutics had annual revenue of $15.03M with 8.91% growth.

Revenue (ttm)
$17.32M
Revenue Growth
+18.76%
P/S Ratio
0.78
Revenue / Employee
$66,095
Employees
262
Market Cap
13.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202415.03M1.23M8.91%
Dec 31, 202313.80M-2.22M-13.87%
Dec 31, 202216.02M-861.00K-5.10%
Dec 31, 202116.89M3.82M29.23%
Dec 31, 202013.07M1.67M14.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IRIDEX 50.65M
Trinity Biotech 48.57M
Lifeward 24.50M
Beyond Air 6.92M
Tenon Medical 3.23M
Sintx Technologies 1.27M
Movano 500.00K
Adagio Medical Holdings 137.00K
Revenue Rankings

VVOS News

More News